Results 61 to 70 of about 210,299 (203)

Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003–2010

open access: yesInternational Journal of Infectious Diseases, 2015
Objective: Since 2006, human papillomavirus (HPV) vaccination has been routinely recommended for adolescent females in the USA. The quadrivalent vaccine induces long-term seropositivity to HPV 6/11/16, which may be useful as a marker for HPV vaccine ...
Emiko Y. Petrosky   +5 more
doaj   +1 more source

Vitamin D effects on Chlamydia trachomatis infection: a case-control and experimental study

open access: yesFrontiers in Cellular and Infection Microbiology
IntroductionVitamin D deficiency is the most common nutritional deficiency worldwide. Chronic vitamin D deficiency causes immune system dysfunction, which increases susceptibility to pathogens such as bacteria, especially intracellular parasites, and ...
Sijia Liu, Tianwei Zhao, Quanzhong Liu
doaj   +1 more source

Acceptability and performance of dual HIV/syphilis testing in male circumcision clients, 2021

open access: yesSouthern African Journal of HIV Medicine
Background: Dual HIV/syphilis testing may be an acceptable intervention to identify men with sexually transmitted infections (STIs) and at risk of HIV acquisition.
Tendesayi Kufa   +12 more
doaj   +1 more source

Ethnomedicinal Survey of Botanicals Used in Treating Sexually Transmitted Diseases in Ekiti State, Nigeria [PDF]

open access: yes, 2008
This paper focuses on the botanicals used in the treatment of sexually transmitted diseases in Ekiti State, Nigeria. The authors identified 49 plants belonging to 30 angiosperm families that were being used by the natives of Ekiti State for the cure of ...
Kayode, G. M., Kayode, J.
core   +1 more source

The Effect of Youth Attitudes Toward the Behaviour Prevention of Sexually Transmitted Diseases in the 3rd Grade of the Islamic Senior High School (Ma) “X”, Sub-district of Mranggen, Demak Regency [PDF]

open access: yes, 2017
Background: STD (Sexually Transmitted Diseases) is a kind of RTI (Reproductive Tract Infections) transmittedthrough sexual intercourses. Bacteria causing such kind of infections can be fungi, viruses and parasites.Women are more susceptible to suffering
Puspitaningrum, D. (Dewi)   +2 more
core   +1 more source

Rush to Judgment: The STI-Treatment Trials and HIV in Sub-Saharan Africa

open access: yes, 2015
Introduction: The extraordinarily high incidence of HIV in sub-Saharan Africa led to the search for cofactor infections that could explain the high rates of transmission in the region.
Akobeng   +76 more
core   +2 more sources

Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting. [PDF]

open access: yes, 2019
The goal of the Sexually Transmitted Infection Clinical Trial Group's Antimicrobial Resistance (AMR) in Neisseria gonorrhoeae (NG) meeting was to assemble experts from academia, government, nonprofit and industry to discuss the current state of research,
Bristow, Claire C   +15 more
core   +1 more source

Genetically Predicted t6A (a tRNA-Derived Adenosine Modification) and Risk of Bullous Pemphigoid: A Two-Sample Mendelian Randomization Study

open access: yesClinical, Cosmetic and Investigational Dermatology
Lulu Yan, Dan Chen, Dehou Yu, Xiaoping Shen Department of Dermatology and Sexually Transmitted Diseases, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, 550004, People’s Republic of ChinaCorrespondence: Xiaoping Shen, Email ...
Yan L, Chen D, Yu D, Shen X
doaj  

Trichomonas and Candida in the Light of Sexually Transmitted Diseases [PDF]

open access: yes, 2009
Trichomonas vaginalis je bičaš koji inficira urogenitalni trakt. Infekcija uzrokuje vaginitis u žena te uretritis i balanopostitis u muškaraca. Glavni put prijenosa je spolni. Infekcija je asimptomatska uglavnom u muškaraca i u polovice inficiranih žena.
Mihael Skerlev, Sanja Špoljar
core   +1 more source

Improved antibody breadth with an extended primary dose interval of COVID-19 vaccine is overcome by boosters

open access: yesFrontiers in Immunology
IntroductionDuring rollout of mRNA-based COVID-19 vaccines, several jurisdictions extended the interval between the first and second doses to prioritize wider population access to limited vaccine supply.
Jessica I. Ahmed   +35 more
doaj   +1 more source

Home - About - Disclaimer - Privacy